JTR  Vol.6 No.4 , December 2018
Vitamin D: Level of Vitamin D3 in AFB Positive PTB Patients in Initial Diagnostic Phase
Background: A relationship among vitamin D and pulmonary tuberculosis. Objective: To conclude the occurrence of Vitamin D insufficiency in subjects suffering from pulmonary TB. Design: This was a cross sectional study. Setting: Current study was performed at department of medicine, Peoples Medical College Hospital Nawabshah starting from January 2017 to December 2017. Samples: 385 AFB positive subjects of pulmonary tuberculosis after achieving the criteria of selection were recruited. Material and Methods: After a brief discussion, the patients were characterized for variable evaluation such as age, gender, sputum AFB and duration of disease and presence of low vitamin D levels. Sputum AFB criterion was used for Data collection. Fasting blood samples were collected for analysis of vitamin D levels in all subjects of AFB positive pulmonary tuberculosis. Results: In 385 diagnosed patients with smear positive PTB, 273 (70.9%) males and 112 (29.1%) were female. Vitamin D levels were within normal or sufficient range in 134 (34.8%), below normal range in 251 (65.2%) cases (insufficient in 09.56% (24/251) and deficient in 90.43% (227/251) cases). Conclusion: Decreased levels of vitamin D were common in subjects with AFB smear Positive PTB cases.
Cite this paper
Jamali, A. , Lighari, J. , Shaikh, S. , Jamali, G. , Tanwani, B. , Channa, M. , Jamali, A. and Suhail, M. (2018) Vitamin D: Level of Vitamin D3 in AFB Positive PTB Patients in Initial Diagnostic Phase. Journal of Tuberculosis Research, 6, 251-269. doi: 10.4236/jtr.2018.64023.
[1]   Kim, J.H., Park, J.S., Cho, Y.J., et al. (2014) Low Serum 25-Hydroxyvitamin D Level: An Independent Risk Factor for Tuberculosis? Clinical Nutrition, 33, 1081-1086.

[2]   Chocano-Bedoya, P. and Ronnenberg, A.G. (2009) Vitamin D and Tuberculosis. Nutrition Reviews, 67, 289-293.

[3]   Huang, S.-J., Wang, X.-H., Liu, Z.-D., Cao, W.-L., Han, Y., Ma, A.-G. and Xu, S.-F. (2017) Vitamin D Deficiency and the Risk of Tuberculosis: A Meta-Analysis. Drug Design, Development and Therapy, 11, 91-102.

[4]   Realegeno, S. and Modlin, R.L. (2011) Shedding Light on the Vitamin D-Tuberculosis-HIV Connection. Proceedings of the National Academy of Sciences of the United States of America, 108, 18861-18862.

[5]   Nnoaham, K.E. and Clarke, A. (2008) Low Serum Vitamin D Levels and Tuberculosis: A Systematic Review and Meta-Analysis. International Journal of Epidemiology, 37, 113-119.

[6]   Liu, P.T., Stenger, S., Li, H., et al. (2006) Toll-Like Receptors Triggering of a Vitamin D Mediated Anti-Microbical Response. Science, 311, 1770-1773.

[7]   Adams, J.S., Ren, S., Liu, P.T., et al. (2009) Vitamin D Directed Rheostatic Regulation of Monocyte Antibacterial Responses. The Journal of Immunology, 182, 4289-4295.

[8]   A National Clinical Guideline (2018) Diagnosis and Management of Drug Susceptible Tuberculosis. Pakistan Chest Society, 4-19.

[9]   Shen, L. and Ji, H.F. (2015) Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson’s Disease: A Meta-Analysis Assessment. Nutrients, 7, 4817-4827.

[10]   Holick, M.F. (2006) High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clinic Proceedings, 81, 353-373.

[11]   Wilkinson, R.J., Llewelyn, M., Toossi, Z., Patel, P., Pasvol, G. and Lalvani, A. (2000) Influence of Vitamin D Deficiency and Vitamin D Receptor Polymorphisms on Tuberculosis among Gujarati Asians in West London: A Case-Control Study. The Lancet, 355, 618-621.

[12]   Talat, N., Perry, S., Parsonnet, J., Dawood, G. and Hussain, R. (2010) Vitamin D Deficiency and Tuberculosis Progression. Emerging Infectious Diseases Journal, 16, 853-855.

[13]   Sita-Lumsden, A., Lapthorn, G., Swaminathan, R. and Milburn, H.J. (2007) Reactivation of Tuberculosis and Vitamin D Deficiency: The Contribution of Diet and Exposure to Sunlight. Thorax, 62, 1003-1007.

[14]   Lemire, J.M. (1992) Immunomodulatory Role of 1,25-Dihydroxyvitamin D3. Journal of Cellular Biochemistry, 49, 26-31.

[15]   Reichel, H., Koeffler, H.P., Tobler, A. and Norman, A.W. (1987) 1 Alpha, 25-Dihydroxyvitamin D3 Inhibits Gamma-Interferon Synthesis by Normal Human Peripheral Blood Lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 84, 3385-3389.

[16]   Rachez, C. and Freedman, L.P. (2000) Mechanisms of Gene Regulation by Vitamin D3 Receptor: A Network of Coactivator Interactions. Gene, 246, 9-21.

[17]   Shaikh, N.S., Jamali, A.A., Jamali, G.M., Jamali, N.H., Rajput, A.A. and Jamali, A.A. (2018) Frequency of Vitamin D Deficiency in Patients with Chronic Kidney Disease Presenting at Siut Karachi. IAJPS, 5, 3525-3532.

[18]   Jamali, A.A., Jamali, G.M., Tanwani, B.M., Jamali, N.H. and Bhatia, M.R. (2018) Frequency of Low Vitamin D3 Levels in Subjects with Parkinson’s Disease. A Study Conducted at PMCH, a Tertiary Care Hospital, Nawabshah. Advances in Parkinson’s Disease, 7, 7-18.

[19]   Jamali, A.A., Tanwani, B.M., Jamali, G.M., et al. (2018) Vitamin D3: Association of Low Vitamin D3 Levels with Semen Abnormalities in Infertile Males. Advances in Sexual Medicine, 8, 39-59.

[20]   Sutaria, N., Liu, C.-T. and Chen, T.C. (2014) Vitamin D Status, Receptor Gene Polymorphisms, and Supplementation on Tuberculosis: A Systematic Review of Case-Control Studies and Randomized Controlled Trials. Journal of Clinical & Translational Endocrinology, 1, 151-160.

[21]   Lips, P. (2001) Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications. Endocrine Reviews, 22, 477-501.

[22]   Xia, J., Shi, L., Zhao, L. and Xu, F. (2014) Review Impact of Vitamin D Supplementation on the Outcome of Tuberculosis Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Chinese Medical Journal, 127, 3127-3134.

[23]   Selvaraj, P., Prabhu Anand, S., Harishankar, M. and Alagarasu, K. (2009) Plasma 1,25Dihydroxy Vitamin D3 Level and Expression of Vitamin D Receptor and Cathelicidin in Pulmonary Tuberculosis. Journal of Clinical Immunology, 29, 470-478.